Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Proteomics. 2016 Dec;16(23):3042–3053. doi: 10.1002/pmic.201600057

Figure 2. Differential enrichment of Aβ and Tau correlate with neuropathological measures.

Figure 2

(A) Detergent insoluble β-amyloid (APP) levels measured by label-free MS quantification correlate with CERAD neuropathological plaque severity scores. (B) Detergent insoluble β-amyloid (APP) levels across individual control (n=5), AsymAD (n=6), MCI (n=11) and AD (n=13) cases. (C) Tau (MAPT) measurements measured by label-free MS quantification correlate with Braak neuropathological measures for aggregated tau. (D) Detergent insoluble β-amyloid (APP) levels across control, AsymAD, MCI and AD cases.